These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22163246)

  • 21. Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease.
    Li DD; Zhang YH; Zhang W; Zhao P
    Front Neurosci; 2019; 13():472. PubMed ID: 31156366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa
    Kim HJ; Shim Y; Han HJ; Kim BC; Park KH; Moon SY; Choi SH; Yang DW; Yoon B; Kim EJ; Jeong JH; Han SH
    Neurol Ther; 2023 Aug; 12(4):1221-1233. PubMed ID: 37245175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence and changes in the dosages of concomitantly used psychotropic drugs associated with the discontinuation of donepezil in severe Alzheimer's disease with behavioral and psychological symptoms on dementia: a preliminary open-label trial.
    Suzuki H; Inoue Y; Mikami K; Gen K
    Ther Adv Psychopharmacol; 2014 Feb; 4(1):37-42. PubMed ID: 24490029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memantine, Donepezil, or Combination Therapy-What is the best therapy for Alzheimer's Disease? A Network Meta-Analysis.
    Guo J; Wang Z; Liu R; Huang Y; Zhang N; Zhang R
    Brain Behav; 2020 Nov; 10(11):e01831. PubMed ID: 32914577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Traditional Chinese medicine Jia Wei Gui Pi Tang improves behavioural and psychological symptoms of dementia and favourable positive emotions in patients.
    Nogami T; Iwasaki K; Kimura H; Higashi T; Arai M; Butler JP; Fujii M; Sasaki H
    Psychogeriatrics; 2023 May; 23(3):503-511. PubMed ID: 37005070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    Carotenuto A; Rea R; Traini E; Fasanaro AM; Ricci G; Manzo V; Amenta F
    J Alzheimers Dis; 2017; 56(2):805-815. PubMed ID: 28035924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
    Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies.
    Manabe Y; Ino T; Yamanaka K; Kosaka K
    Psychogeriatrics; 2016 May; 16(3):202-8. PubMed ID: 26179411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease.
    Ishikawa I; Shinno H; Ando N; Mori T; Nakamura Y
    Acta Neuropsychiatr; 2016 Jun; 28(3):157-64. PubMed ID: 26572055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
    Gauthier S; Loft H; Cummings J
    Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial).
    Knapp M; King D; Romeo R; Adams J; Baldwin A; Ballard C; Banerjee S; Barber R; Bentham P; Brown RG; Burns A; Dening T; Findlay D; Holmes C; Johnson T; Jones R; Katona C; Lindesay J; Macharouthu A; McKeith I; McShane R; O'Brien JT; Phillips PPJ; Sheehan B; Howard R
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1205-1216. PubMed ID: 27739182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P
    Drugs Aging; 2019 May; 36(5):435-452. PubMed ID: 30937879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis.
    Chen R; Chan PT; Chu H; Lin YC; Chang PC; Chen CY; Chou KR
    PLoS One; 2017; 12(8):e0183586. PubMed ID: 28827830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer's disease: A clinical trial.
    Zhou T; Wang J; Xin C; Kong L; Wang C
    Exp Ther Med; 2019 Mar; 17(3):1625-1630. PubMed ID: 30783429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice.
    Yabuki Y; Matsuo K; Hirano K; Shinoda Y; Moriguchi S; Fukunaga K
    Pharmacology; 2017; 99(3-4):160-171. PubMed ID: 28049192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Behavioral Effects of Combination Therapy of Memantine and Acetylcholinesterase Inhibitors Compared with Acetylcholinesterase Inhibitors Alone in Patients with Moderate Alzheimer's Dementia: A Double-Blind Randomized Placebo-Controlled Trial.
    Youn H; Lee KJ; Kim SG; Cho SJ; Kim WJ; Lee WJ; Hwang JY; Han C; Shin C; Jung HY
    Psychiatry Investig; 2021 Mar; 18(3):233-240. PubMed ID: 33685036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease.
    Paleacu D; Mazeh D; Mirecki I; Even M; Barak Y
    Clin Neuropharmacol; 2002; 25(6):313-7. PubMed ID: 12469005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer's disease receiving donepezil.
    Kano O; Ito H; Takazawa T; Kawase Y; Murata K; Iwamoto K; Nagaoka T; Hirayama T; Miura K; Nagata R; Kiyozuka T; Aoyagi J; Sato R; Eguchi T; Ikeda K; Iwasaki Y
    Neuropsychiatr Dis Treat; 2013; 9():259-65. PubMed ID: 23431041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.